Vitamin D3 24-hydroxylase mRNA expression in the skin of calcipotriol-treated psoriatic patients correlates with clinical efficacy

Arch Dermatol Res. 2003 Nov;295(6):269-71. doi: 10.1007/s00403-003-0428-1. Epub 2003 Sep 23.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcitriol / administration & dosage*
  • Calcitriol / analogs & derivatives*
  • Cytochrome P-450 Enzyme System / genetics*
  • Dermatologic Agents / administration & dosage*
  • Humans
  • Psoriasis / drug therapy*
  • Psoriasis / physiopathology*
  • RNA, Messenger / analysis
  • Skin / drug effects*
  • Skin / enzymology
  • Steroid Hydroxylases / genetics*
  • Treatment Outcome
  • Vitamin D3 24-Hydroxylase

Substances

  • Dermatologic Agents
  • RNA, Messenger
  • calcipotriene
  • Cytochrome P-450 Enzyme System
  • Steroid Hydroxylases
  • Vitamin D3 24-Hydroxylase
  • Calcitriol